Delivery Order SPE2DB22D3301-SPE2DB23FZ1ZU
Award Date 7/26/23
Potential Completion Date 8/16/23
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,206.51 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of EXJADE 500 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen Drug Corp's primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical...
- This is a delivery order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, with a firm fixed price and a ceiling value of $4,006.76. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,684.20 firm fixed-price delivery order is for the provision of 4558286473 EXJADE 500 MG TABLET 30S, with a completion date of September 21, 2022. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,027.08 for Exjade 500 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract, which is not set-aside, represents a routine pharmaceutical supply requirement fulfilled by the prime contractor at its Conshohocken, Pennsylvania facility. The award is issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $20,177 to Amerisourcebergen Drug Corporation to supply 4561689566 EXJADE 500 MG TABLET 30S. The order was issued against an indefinite delivery/indefinite quantity contract vehicle and will be performed in Conshohocken, Pennsylvania over a three week period concluding in mid-August. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXJADE 250 MG TABLET 30S. The contract has a potential value of $3,418.22 and a completion date of January 25, 2024. The contract supports the provision of pharmaceuticals and medical supplies to military treatment programs and facilities. No set-aside designation was used for this award....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,363 to Amerisourcebergen Drug Corporation to supply 30 bottles of Exjade 500 mg tablets. The order is to be performed in Conshohocken, Pennsylvania by September 26, 2023 with Amerisourcebergen Corporation as the prime contractor. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports numerous defense programs, indicating this order is likely to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,467.36 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a medication, with a period of performance through May 20, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a specific pharmaceutical product, JADENU 360 MG TABLET 30S, to the U.S. government. The $22,001.04 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD), and has a completion date of May 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ1ZUDelivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier, to provide EXJADE 125 MG TABLET 30S for $6,761.12. This order is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the Department of Defense and other government agencies. The contract does not have a set-aside designation.
Generated 9/17/24, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/26/23 |